Brief: Point Biopharma Global Posts Quarterly Loss Per Share Of 16 Cents
March 25 (Reuters) - POINT Biopharma Global Inc PNT.O :
* QUARTERLY LOSS PER SHARE $0.16
* POINT BIOPHARMA GLOBAL- AS OF DEC 31, 2021, HAD ABOUT
$238.8
MILLION IN CASH AND CASH EQUIVALENTS, WHICH IS ANTICIPATED TO
FUND OPERATIONS INTO Q1 OF 2024
* Q4 EARNINGS PER SHARE VIEW $-0.24 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1F56bs
Further company coverage: PNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower